4//SEC Filing
Allison David D. 4
Accession 0001415889-24-010566
CIK 0001445499other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:17 PM ET
Size
10.4 KB
Accession
0001415889-24-010566
Insider Transaction Report
Form 4
Allison David D.
Director
Transactions
- Other
Stock Option (right to buy)
2024-04-05−13,222→ 0 totalExercise: $1.34Exp: 2033-06-15→ Common Stock (13,222 underlying) - Other
Stock Option (right to buy)
2024-04-05−12,789→ 0 totalExercise: $8.65Exp: 2032-06-15→ Common Stock (12,789 underlying) - Other
Stock Option (right to buy)
2024-04-05−11,500→ 0 totalExercise: $9.96Exp: 2031-07-10→ Common Stock (11,500 underlying)
Footnotes (3)
- [F1]Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery.
- [F2]The option was fully vested.
- [F3]The option was scheduled to vest in full as of June 16, 2024.
Documents
Issuer
IPI Legacy Liquidation Co
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001853903
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 4:17 PM ET
- Size
- 10.4 KB